Health ❯ Healthcare ❯ Pharmaceuticals ❯ Medications

GLP-1 Receptor Agonists

Novo Nordisk Forecasts Up to 13% 2026 Sales and Profit Decline as U.S. Price Cuts Bite

Lower U.S. prices, intensifying competition, patent expiries prompted the downgrade.

WHO Backs Long-Term GLP-1 Use for Obesity in First Global Guideline

WHO Endorses GLP‑1s for Obesity as Australia Adds Class‑Wide Mental Health Warning

Costco to Offer Ozempic and Wegovy for $499 a Month to Self-Pay Members Nationwide

Australian Study Finds Contraception Gaps and Pregnancies After GLP-1 Weight-Loss Prescriptions

Lilly’s Orforglipron Pill Hits Phase 3 Goals, Clearing Path to Global Filings

GLP-1 Agonists Tied to Higher Risk of Macular Degeneration and Rare Optic Neuropathy